Investor Relations Captor Therapeutics ®

Selected Financial Data

Consolidated statement of financial position

(PLN, thousand) wykres słupkowy

Available funding secured

(PLN M; as of 31.03.2023) wykres kołowy

Selected financial data for the period of 6 years

  From 1 January to 31 December For the period of 6 months ended 30 June
  2023 2022 2021 2020 2019 2018* 2023 2022 2021 2020 2019**
Income (Research and development income and Other operating income) 31.560 32.004 28.629 21.617 15.968 9.909 12.446 13.766 11.227 12.486 7.128
Operating profit (loss) -73.016 -38.364 -31.709 -12.216 -7.855 -4.130 -45.177 -20.850 -12.130 -4.487 -2.875
Net profit (loss) -70.584 -35.894 -32.572 -12.694 -8.306 -4.422 -43.323 -20.840 -12.801 -4.790 -3.109
Net profit (loss) attributable to the shareholders of the parent company -70.584 -35.849 -32.572 -12.694 -8.306 -4.422 -43.323 -20.840 -12.801 -4.790 -3.109

 

Source:CONSOLIDATED FINANCIAL STATEMENTS,
*consolidated report was not subject to audit,
**interim  consolidated report was not subject to audit